Leading the Way

Leading the Way Small to Medium Pharma . . . those who worked in small to medium sized organisations had 27% greater levels of...

Never mind the width, feel the quality!

Paul Midgley of the Healthcare Partnership reviews the impending new GMS contract-related ‘Quality and Outcomes framework’ (QOF) practice assessment visits that every PCT will...

The Matrix – Do you have Customer Agreement?

As the discussion continues I see one or two objections to her reasoning. Firstly, I don’t think that her company’s statistics on cost-effectiveness is...

ABPI Comment

Responding to Government proposals to extend legislation to tackle animal rights extremism, Dr Trevor Jones, Director General of the Association of the British Pharmaceutical...

Movements in the NHS

Community pharmacists have a lot going for them. They know a great deal about medicines, they are spread around the community and, so far,...

Good Morning, Sunshine!

Every day you may make progress. Every step may be fruitful. Yet there will stretch out before you an ever-lengthening, ever-ascending, ever-improving path. You...

CDM – the New Frontier

There has been change in the NHS almost from the moment it began. The compromises that had to be made to get it going...

THE MATRIX The Tell Sell! Customer Neurolinguistics!

Part 1 The impetus for this article came from a chance discussion with a moderately senior pharma company representative. They were explaining the...

Statins go OTC in Britain

Over-the-counter (OTC) drugs are medications available to consumers without a prescription. Millions of consumers each year use these formulations for the treatment of self-diagnosed...

Mergers and Acquisitions deals impacted by Corporate Social Responsibility risks

* Survey finds a third of Europe’s largest companies are hit by material environmental liabilities post deal. * Brand and reputation are increasingly the...

Latest articles

Shareholders approve proposed acquisition of Allergan by AbbVie

Shareholders approve proposed acquisition of Allergan by AbbVie

Following the June announcement of the proposed acquisition of Allergan by Abbvie, Allergan has announced that its shareholders have voted to approve the proposed...
Research identifies cause of IBS pain as 'gut itch'

Research identifies cause of IBS pain as ‘gut itch’

New research has identified the cause of IBS pain as 'gut itch'. 11 percent of the world’s population experience Irritable Bowel Syndrome (IBS), but the...
The annual assessment of health and social care in England

The annual assessment of health and social care in England

The Care Quality Commission (CQC) has published its annual assessment of health and social care in England. It looks at the trends, highlights examples...

Popular articles

Business man sheltered: ABPI complaints against sales representatives

ABPI complaints against sales representatives: mitigating the risk

Rina Newton, Managing Director of CompliMed, explores ABPI complaints against sales representatives and considers ways in which pharmaceutical companies could mitigate the risk of...
Data: Paul Midgley, part of Wilmington Healthcare’s Consulting Team, takes a look at NHSX, the NHS’ new joint organisation for digital, data and technology

Digital transformation of the NHS

Paul Midgley, part of Wilmington Healthcare’s Consulting Team, takes a look at NHSX, the NHS’ new joint organisation for digital, data and technology. NHSX, which...
Business man juggling: Building a new pharmaceutical company

Building a new pharmaceutical company

Nick Saunders, Commercial Operations (UK) and Brand Director at Theramex, won the Hospital Representative Pf Award at the Pf Awards in 2000. It directly...
Medicines and Medical Devices Bill could improve access to new dementia treatments

Medicines Bill could improve access to new dementia treatments

The Government has announced new legislation aimed at providing faster access to medicines. The Medicines and Medical Devices Bill, announced in the Queen’s Speech...
pain relief patch released by nurofen

Nurofen launches a 24 hour ibuprofen pain relief patch

Nurofen announces the launch of the UK’s only 24 hour clinically proven pain relief patch containing ibuprofen.  Despite body pain being among the most commonly...

Subscribe

Sign up to receive your free UK subscription to Pf Magazine and our digital newsletters, for all the essential headlines, Jobs of the Week, and thought-provoking features.

Claim my free subscription